Stock screener
Filter the covered US universe by sector, size, profitability, dividends and performance. Every screen has its own shareable link — the address bar reflects your filters.
Showing 91–120 of 574 companies · sorted by market cap (high to low)
| Ticker | Company | Sector | Price | Market cap | P/E | Rev growth | Net margin | Div yield | 1y return |
|---|---|---|---|---|---|---|---|---|---|
| HALO | Halozyme | Health Care | $77.82 | $9.3B | 26.7 | +39.1% | +23.1% | n/a | +35.2% |
| BRKR | Bruker | Health Care | $59.74 | $9.1B | n/a | +0.4% | -0.3% | +0.3% | +54.0% |
| KYMR | KYMERA THERAPEUTICS INC | Health Care | $110.34 | $9.1B | n/a | -12.6% | -612.0% | n/a | +151.2% |
| UHS | Universal Health Services | Health Care | $149.34 | $9.1B | 6.0 | +10.4% | +8.6% | +0.5% | -8.2% |
| GKOS | GLAUKOS CORP | Health Care | $152.86 | $8.9B | n/a | +36.3% | -34.3% | n/a | +58.3% |
| CRNX | CRINETICS PHARMACEUTICALS INC | Health Care | $83.72 | $8.9B | n/a | +2277.5% | -2747.2% | n/a | +171.1% |
| ALKS | ALKERMES | Health Care | $52.58 | $8.8B | 57.7 | +3.2% | +9.8% | n/a | +94.5% |
| IONS | Ionis Pharmaceuticals | Health Care | $54.01 | $8.8B | n/a | +47.4% | -30.9% | n/a | +28.5% |
| PTGX | PROTAGONIST THERAPEUTICS INC | Health Care | $135.44 | $8.7B | n/a | -64.4% | -154.9% | n/a | +146.3% |
| PRAX | PRAXIS PRECISION MEDICINES INC | Health Care | $312.10 | $8.7B | n/a | n/a | -2137.5% | n/a | +476.3% |
| SYRE | SPYRE THERAPEUTICS INC | Health Care | $99.17 | $8.6B | n/a | n/a | -22158.5% | n/a | +501.4% |
| TEM | Tempus AI | Health Care | $46.96 | $8.4B | n/a | +69.8% | -22.2% | n/a | -23.1% |
| QGEN | Qiagen | Health Care | $40.57 | $8.4B | 20.8 | +4.8% | +19.2% | +0.6% | -18.1% |
| TGTX | TG THERAPEUTICS INC | Health Care | $52.68 | $8.3B | 17.9 | +81.3% | +66.0% | n/a | +41.0% |
| BIO | Bio-Rad Laboratories | Health Care | $305.96 | $8.2B | 48.8 | +1.9% | +6.5% | n/a | +24.6% |
| HQY | HEALTHEQUITY INC | Health Care | $95.95 | $8.2B | 35.4 | +7.6% | +17.3% | n/a | -1.5% |
| PCVX | VAXCYTE INC | Health Care | $56.00 | $8.1B | n/a | n/a | n/a | n/a | +56.8% |
| IMVT | IMMUNOVANT INC | Health Care | $39.05 | $8.0B | n/a | n/a | n/a | n/a | +123.3% |
| IBRX | IMMUNITYBIO INC | Health Care | $7.51 | $8.0B | n/a | +351.5% | -606.1% | n/a | +177.1% |
| RGEN | Repligen | Health Care | $140.09 | $7.9B | 153.8 | +18.2% | +6.7% | n/a | +22.8% |
| LQDA | LIQUIDIA CORP | Health Care | $87.04 | $7.7B | 347.0 | +1936.7% | +7.7% | n/a | +424.3% |
| AVTR | Avantor | Health Care | $10.95 | $7.5B | n/a | -2.0% | -8.4% | n/a | -10.9% |
| HIMS | HIMS HERS HEALTH INC CLASS A | Health Care | $31.68 | $7.3B | 57.1 | +32.8% | -0.6% | n/a | -31.2% |
| PACS | PACS GROUP INC | Health Care | $45.06 | $7.2B | 29.7 | +140.5% | +4.5% | n/a | +292.1% |
| RYTM | RHYTHM PHARMACEUTICALS INC | Health Care | $103.97 | $7.1B | n/a | +58.7% | -93.3% | n/a | +18.4% |
| MIRM | MIRUM PHARMACEUTICALS INC | Health Care | $114.48 | $7.0B | n/a | +50.2% | -140.2% | n/a | +119.4% |
| LNTH | LANTHEUS HOLDINGS INC | Health Care | $104.61 | $6.8B | 24.5 | +0.6% | +18.1% | n/a | +44.6% |
| ERAS | ERASCA INC | Health Care | $19.51 | $6.8B | n/a | n/a | n/a | n/a | +1192.0% |
| COGT | COGENT BIOSCIENCES INC | Health Care | $39.54 | $6.8B | n/a | n/a | -264.1% | n/a | +222.3% |
| CHE | Chemed Corporation | Health Care | $503.52 | $6.7B | 25.9 | +2.1% | +10.2% | +0.5% | +11.2% |
This is a shareable URL: filters live in the query string — e.g.
/browse?sector=Health+Care, /browse?index=russell2000,
/browse?mktcap=small, /browse?pe_band=under15,
/browse?growth_band=over20, /browse?margin_band=over20,
/browse?div_yield_band=over4, /browse?div_streak=ge10,
/browse?insider=cluster-buy, /browse?holder=blackrock,
/browse?short=elevated.
Combine them, sort with &sort=dividend_yield&dir=desc (or click a column
header), and page with &page=2.
Data: SEC EDGAR (filings) + Finnhub (prices, fundamentals), as of 2026-07-23 close. Prices are delayed daily-close, labelled with their as-of date.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date. Past performance does not indicate future results.